1. Jaffe ES, Harris NL, Stein H,Vardiman JW. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001.
2. Gaidano G, Pasqualucci L, Capello D, et al. Aberrant somatic hypermutation in multiple subtypes of AIDS-associated non-Hodgkin lymphoma. Blood. 2003;102:1833-1841.
3. Gaidano G, Carbone A, Dalla-Favera R. Genetic basis of acquired immunodeficiency syndrome-related lymphomagenesis. J Natl Cancer Inst Monogr. 1998;23:95-100.
4. Carbone A. Emerging pathways in the development of AIDS-related lymphomas. Lancet Oncol. 2003;4:22-29.
5. Knowles DM. Neoplastic Hematopathology. 2nd ed. Baltimore: Williams and Wilkins; 2001.
6. Raphael M, Borisch B, Jaffe ES. Lymphomas associated with infection by the human immune deficiency virus (HIV). In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumors, Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001:260-263.
7. Nalesnik MA, Jaffe R, Starzl TE, et al. The pathology of posttrans-plant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol. 1988; 133:173-192.
8. Knowles DM, Cesarman E, Chadburn A, et al. Correlative morphologic and molecular genetic analysis demonstrates three distinct categories of posttransplantation lymphoproliferative disorders. Blood. 1995;85:552-565.
9. Cesarman E, Chadburn A, Liu YF, Migliazza A, Dalla-Favera R, Knowles DM. BCL-6 gene mutations in posttransplantation lym-phoproliferative disorders predict response to therapy and clinical outcome. Blood. 1998;92:2294-2302.
10. Shapiro RS, McClain K, Frizzera G, et al. Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. Blood. 1988;71:1234-1243.
11. Chadburn A, Hyjek E, Frizzera G, et al. Post-transplantation lym-phoproliferative disorders (PT-LPDs) in bone marrow and solid organ transplant recipients differ. Blood. 2000;96(suppl 1):505a.
12. Abed N, Casper JT, Camitta BM, et al. Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lympho-proliferative disorders. Bone Marrow Transplant. 2004;33:321-327.
13. Chadburn A, Hyjek E, Pan L, et al. Bcl-6 gene mutations in bone marrow transplantation (BMT). Mod Pathol. 2001;14:167A.
14. Chadburn A, Chen JM, Hsu DT, et al. The morphologic and molecular genetic categories of posttransplantation lymphoproliferative disorders are clinically relevant. Cancer. 1998;82:1978-1987.
15. Leblond V, Davi F, Charlotte F, et al. Posttransplant lymphoprolifer-ative disorders not associated with Epstein-Barr virus: a distinct entity? J Clin Oncol. 1998;16:2052-2059.
16. Choquet S, Mamzer BM, Hermine O, et al. Identification of prognostic factors in post-transplant lymphoproliferative disorders. Recent Results Cancer Res. 2002;159:67-80.
17. Hoshino Y, Kimura H, Kuzushima K, et al. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load. Bone Marrow Transplant. 2000;26:199-201.
18. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Oster-haus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol. 2000;38:712-715.
19. Fan H, Gulley ML. Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn. 2001;6:279-289.
20. Gulley ML. Molecular diagnosis of Epstein-Barr virus-related diseases. J Mol Diagn. 2001;3:1-10.
21. van Esser JW, Niesters HG, Thijsen SF, et al. Molecular quantification of viral load in plasma allows for fast and accurate prediction of response to therapy of Epstein-Barr virus-associated lymphoprolif-erative disease after allogeneic stem cell transplantation. Br J Haematol. 2001;113:814-821.
22. Clave E, Agbalika F, Bajzik V, et al. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy. Transplantation. 2004;77:76-84.
23. Gartner BC, Schafer H, Marggraff K, et al. Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoprolifer-ative disease. J Clin Microbiol. 2002;40:351-358.
24. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell. 1986;47:883-889.
25. Leung E, Shenton BK, Jackson G, Gould FK, Yap C, Talbot D. Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J. Immunol. Methods. 2002;270:259-267.
26. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol. 1992;66:2689-2697.
27. Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994;266:1865-1869.
28. Pan L, Milligan L, Michaeli J, Cesarman E, Knowles DM. Polymerase chain reaction detection of Kaposi's sarcoma-associated her-pesvirus-optimized protocols and their application to myeloma. J Mol Diagn. 2001;3:32-38.
29. Cesarman E. Epstein-Barr virus (EBV) and lymphomagenesis. Front Biosci. 2002;7:e58-e65.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.